BSAC standardized disc susceptibility testing method (version 10)

被引:73
作者
Andrews, J. M. [1 ]
Howe, R. A. [2 ]
机构
[1] City Hosp, Sandwell & W Birmingham NHS Trust, Dept Microbiol, Birmingham B18 7QH, W Midlands, England
[2] Univ Wales Hosp, NPHS Microbiol Cardiff, Cardiff CF14 4XW, S Glam, Wales
关键词
breakpoints; disc testing; MICs;
D O I
10.1093/jac/dkr359
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The BSAC standardized disc susceptibility testing method remains unchanged, but there are considerable changes to the interpretative criteria due to continuing harmonization with the European Committee on Antimicrobial Susceptibility Testing (EUCAST) MIC breakpoints. There are a number of agents for which interpretative criteria have been removed. These MIC and/or zone diameter breakpoints will be published on the BSAC web site as a 'Legacy' table; they may be used for research or comparative purposes, but are not recommended for clinical management. Notably, testing of staphylococci for susceptibility to glycopeptides by disc diffusion has been removed because this method has been found to be unreliable, particularly for the detection of low-level resistance; low-level vancomycin resistance in staphylococci is increasingly deemed to be of clinical relevance. The tables for anaerobes have been expanded to include MIC breakpoints that have been determined by EUCAST. There are currently no zone diameter breakpoints for these organisms and an MIC method is recommended if susceptibility testing is required.
引用
收藏
页码:2726 / 2757
页数:32
相关论文
共 4 条
[1]   BSAC standardized disc susceptibility testing method (version 8) [J].
Andrews, J. M. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 64 (03) :454-489
[2]   Guidelines for the antibiotic treatment of endocarditis in adults: report of the Working Party of the British Society for Antimicrobial Chemotherapy [J].
Elliott, TSJ ;
Foweraker, J ;
Gould, FK ;
Perry, JD ;
Sandoe, JAT .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 54 (06) :971-981
[3]   Risk factors for persistent carriage of methicillin-resistant Staphylococcus aureus [J].
Harbarth, S ;
Liassine, N ;
Dharan, S ;
Herrault, P ;
Auckenthaler, R ;
Pittet, D .
CLINICAL INFECTIOUS DISEASES, 2000, 31 (06) :1380-1385
[4]  
Health Protection Agency, ADV CARB PROD REC IN